These three pathways are not mutually exclusive
doi:10.1074/jbc.R113.458810
Compared with conventional synthetic drugs, these biologic agents offer multiple advantages
Yes it is the most common pairing in tissue-repair research, and the rationale is sound: BPC-157 acts locally at an injury site, TB-500 acts systemically across the body
The pain is usually confined to one side of the face and follows the distribution of the trigeminal nerve branches, affecting areas such as the cheek, jaw, lips, gums, or forehead
No human study has tracked cancer incidence following BPC-157 administration, leaving the oncological risk profile unresolved and requiring cautious evaluation before use in individuals with active or prior malignancies